EP Patent

EP4272827A2 — Method of treating epilepsy

Assigned to Alexza Pharmaceuticals Inc · Expires 2023-11-08 · 3y expired

What this patent protects

Alprazolam formulated as an inhaled condensation aerosol and method for treating epilepsy and/or seizures.

USPTO Abstract

Alprazolam formulated as an inhaled condensation aerosol and method for treating epilepsy and/or seizures.

Drugs covered by this patent

Valium (diazepam) · Generic (originally Roche)

Patent Metadata

Patent number: EP4272827A2
Jurisdiction: EP
Classification: —
Expires: 2023-11-08
Drug substance claim: No
Drug product claim: No
Assignee: Alexza Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.